Feb 2010;5(2):299-306
Emerging Safety Concerns Recent research has identified new safety considerations beyond traditional gastrointestinal effects
Studies have confirmed that in the context of diabetes, various pathogenic stimuli, including hyperglycemia and the accumulation of advanced glycation end products (AGEs), can induce renal parenchymal cells to undergo cellular senescence (Liu et al., 2015
doi:10.1038/s41392-024-01951-9 Uusitupa M, Khan TA, Viguiliouk E, et al
for example, semaglutide (injectable) or tirzepatide (injectable) are not oral
GSH imbalance and depletion are reported in many other brain disorders, including autism [28,29], bipolar disorder [30], schizophrenia [31], amyotrophic lateral sclerosis [32], and multiple sclerosis [33]